JACC-Heart Failure

Scope & Guideline

Pioneering Research in Cardiovascular Health

Introduction

Welcome to the JACC-Heart Failure information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JACC-Heart Failure, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2213-1779
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2013 to 2024
AbbreviationJACC-HEART FAIL / JACC-Heart Fail.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal 'JACC: Heart Failure' focuses on the advancement of knowledge in the field of heart failure through rigorous research and clinical insights. It emphasizes the importance of guideline-directed medical therapy, innovative treatment strategies, and the management of comorbid conditions associated with heart failure.
  1. Heart Failure Management Strategies:
    The journal covers clinical trials and studies focusing on the management of heart failure, including pharmacological interventions, device therapy, and rehabilitation approaches.
  2. Epidemiology and Risk Factors:
    Research on the epidemiology of heart failure, including the identification of risk factors, comorbidities, and social determinants of health that influence patient outcomes.
  3. Innovative Therapies and Technologies:
    Exploration of new therapeutic strategies, including the use of sodium-glucose cotransporter inhibitors, novel devices, and digital health technologies for heart failure management.
  4. Patient-Centered Care:
    Emphasis on the importance of patient-reported outcomes, quality of life assessments, and the integration of patient preferences in heart failure treatment plans.
  5. Guideline-Directed Medical Therapy (GDMT):
    Studies focusing on the implementation, adherence, and optimization of GDMT in diverse populations, including challenges faced in clinical practice.
  6. Health Disparities in Heart Failure:
    Investigation into disparities in heart failure care and outcomes based on race, ethnicity, gender, and socioeconomic status.
Recent publications in 'JACC: Heart Failure' reveal several emerging themes that reflect the evolving landscape of heart failure research, focusing on innovative approaches, personalized medicine, and comprehensive care models.
  1. Digital Health and Telemedicine:
    A significant increase in studies exploring the use of digital health technologies, telemedicine, and remote patient monitoring for managing heart failure, especially post-COVID-19.
  2. SGLT2 Inhibitors and Heart Failure:
    Growing research interest in the application of SGLT2 inhibitors for heart failure management, highlighting their benefits beyond diabetes control and their impact on heart failure outcomes.
  3. Comorbid Conditions and Integrated Care:
    Emerging focus on the management of comorbidities alongside heart failure, particularly in relation to chronic kidney disease, obesity, and mental health, emphasizing a holistic approach to patient care.
  4. Health Equity and Social Determinants of Health:
    Increasing attention on health disparities and social determinants affecting heart failure outcomes, driving research that seeks to address inequities in access to care and treatment.
  5. Personalized Medicine Approaches:
    A trend towards personalized treatment strategies in heart failure, incorporating genetic, phenotypic, and biomarker data to tailor therapies to individual patient needs.

Declining or Waning

While 'JACC: Heart Failure' continues to thrive in many areas of research, certain themes are becoming less prominent in recent publications. These waning scopes reflect shifts in clinical focus and emerging evidence that may influence future research directions.
  1. Traditional Heart Failure Biomarkers:
    Research on conventional biomarkers like BNP and NT-proBNP is seeing a decline as newer, more comprehensive diagnostic approaches and biomarkers gain traction in heart failure management.
  2. Invasive Procedures for Diagnosis and Management:
    There is a noticeable decrease in studies centered on invasive procedures, such as routine cardiac biopsies or catheterizations, as non-invasive and remote monitoring technologies are increasingly preferred.
  3. Single-Factor Studies:
    Research focusing solely on single interventions or factors in heart failure is declining in favor of multi-faceted approaches that consider the complexity of patient care and the interaction of various treatment modalities.

Similar Journals

CURRENT PROBLEMS IN CARDIOLOGY

Driving Progress in Heart Health Research
Publisher: MOSBY-ELSEVIERISSN: 0146-2806Frequency: 12 issues/year

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.

Netherlands Heart Journal

Transforming Cardiology Insights into Global Health Solutions
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

American Heart Journal Plus: Cardiology Research and Practice

Bridging Research and Practice in Cardiology
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

American Heart Journal Plus: Cardiology Research and Practice, published by Elsevier, is a prominent open-access platform dedicated to advancing knowledge in the field of cardiology. With an evolving ISSN of 2666-6022, this journal serves as a vital resource for cardiologists, researchers, and healthcare professionals, contributing to the ever-growing discourse surrounding cardiovascular health. With a mission to disseminate high-quality research and innovative practices from 2021 to 2024, it aims to bridge the gap between scientific research and clinical application. Though currently ranked #264 out of 387 in the medicine category for cardiology and cardiovascular medicine, its commitment to quality and accessibility exemplifies the journal's importance in fostering collaboration and knowledge sharing within the medical community. Researchers are encouraged to take advantage of its open-access model to ensure that groundbreaking developments in cardiology are readily available to all stakeholders in the field.

BASIC RESEARCH IN CARDIOLOGY

Advancing cardiac science through groundbreaking research.
Publisher: SPRINGER HEIDELBERGISSN: 0300-8428Frequency: 6 issues/year

BASIC RESEARCH IN CARDIOLOGY, published by SPRINGER HEIDELBERG, is an esteemed peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine since 1973. With a strong emphasis on the latest breakthroughs in basic and translational research, this journal offers a platform for high-quality, impactful studies that contribute to our understanding of cardiac function and related physiological processes. Currently ranked in the Q1 category in Cardiology and Cardiovascular Medicine, as well as Physiology and Medical Physiology, BASIC RESEARCH IN CARDIOLOGY is recognized as a leading journal within these disciplines, boasting impressive Scopus ranks that place it in the top tiers of global research output. While it does not offer open access, its contributions are pivotal for researchers, clinicians, and students seeking to stay abreast of cutting-edge discoveries and methodologies in cardiovascular science. With its commitment to scholarly excellence, this journal plays a critical role in shaping the future of cardiac research and clinical practice.

HEART & LUNG

Pioneering Insights for Better Patient Outcomes
Publisher: MOSBY-ELSEVIERISSN: 0147-9563Frequency: 6 issues/year

HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

ESC Heart Failure

Bridging gaps in heart failure research and clinical application.
Publisher: WILEY PERIODICALS, INCISSN: 2055-5822Frequency: 6 issues/year

ESC Heart Failure is a premier academic journal dedicated to the field of cardiology, specifically focusing on heart failure and its management. Published by WILEY PERIODICALS, INC, this esteemed journal has been an open access publication since 2014, making cutting-edge research readily accessible to a global audience. With its impressive impact factor and recent classification as a Q1 journal in Cardiology and Cardiovascular Medicine for 2023, ESC Heart Failure stands out as a leading resource with a Scopus ranking of #68 out of 387 in its field, placing it in the 82nd percentile. The journal aims to disseminate vital research findings, reviews, and clinical insights that advance the understanding and treatment of heart failure, thereby supporting healthcare professionals, researchers, and students in enhancing patient care. Its commitment to quality and relevance makes ESC Heart Failure an essential publication for anyone involved in cardiovascular medicine.

Korean Circulation Journal

Fostering Evidence-Based Practices in Cardiovascular Care.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Journal of Cardiology

Driving breakthroughs in heart health and patient care.
Publisher: ELSEVIERISSN: 0914-5087Frequency: 12 issues/year

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.

Heart International

Connecting researchers and clinicians in the pursuit of heart health.
Publisher: TOUCH MEDICAL MEDIA LTDISSN: 2036-2579Frequency: 2 issues/year

Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.

Egyptian Heart Journal

Connecting practitioners and researchers in the heart of science.
Publisher: SPRINGERISSN: 1110-2608Frequency: 1 issue/year

The Egyptian Heart Journal, published by Springer, is a premier open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. As of 2023, it holds a Q3 classification within the category, showcasing its growing influence within the research community, and ranks 241 out of 387 in Scopus, reflecting a 37th percentile position. With an E-ISSN of 2090-911X, this journal has been open access since 2011, making it easily accessible to researchers, practitioners, and students alike. The journal aims to disseminate high-quality research articles, reviews, and case studies that contribute to the understanding and treatment of cardiovascular diseases. With its focus on innovative and practical solutions in cardiology, the Egyptian Heart Journal plays a critical role in shaping current and future cardiovascular research. Its global outreach and commitment to open access ensure that vital information is available to a wide audience, enhancing both scholarly discourse and clinical practice in the evolving landscape of cardiovascular medicine.